New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma

H3K27M-mutant diffuse midline gliomas (DMGs) are rare childhood central nervous system tumors that carry a dismal prognosis. Thus, innovative treatment approaches are greatly needed to improve clinical outcomes for these patients. Here, we discuss current trends in research of H3K27M-mutant diffuse...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Davis P. Argersinger, Sarah R. Rivas, Ashish H. Shah, Sadhana Jackson, John D. Heiss
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/b9777d6178d8452eb0ff36817324d0b9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!